Serum Creatinine Amount

Creatinine is a waste product generated from the normal breakdown of creatine phosphate, a molecule stored in muscles that provides energy for muscle contraction. The amount of creatinine produced daily is relatively stable and proportional to an individual’s muscle mass.

Biological Basis

Once produced, creatinine is released into the bloodstream and transported to the kidneys. The kidneys are primarily responsible for filtering creatinine from the blood through a process called glomerular filtration. A small amount is also secreted by the renal tubules. Because creatinine is freely filtered by the glomeruli and minimally reabsorbed, its concentration in the blood, known as serum creatinine, is a key indicator of kidney function. Healthy kidneys efficiently remove creatinine, maintaining low serum levels.

Clinical Relevance

Measuring serum creatinine amount is a standard diagnostic tool in medicine, primarily used to estimate the glomerular filtration rate (GFR), which reflects how well the kidneys are filtering blood. Elevated serum creatinine levels often indicate impaired kidney function or kidney disease^[1]. Conditions such as chronic kidney disease (CKD) are frequently monitored through serum creatinine levels, which can also be associated with kidney stones^[2]. Variations in serum creatinine can be influenced by factors like age, muscle mass, diet, and certain medications, making it important to interpret results in context.

Social Importance

The widespread use of serum creatinine testing holds significant social importance by facilitating the early detection and management of kidney diseases, which are often asymptomatic in their initial stages. Early diagnosis through markers like serum creatinine can allow for interventions that slow disease progression and prevent severe complications, thereby improving public health outcomes. Research also suggests a familial clustering of chronic kidney disease, highlighting the importance of understanding both environmental and genetic factors that influence kidney function and serum creatinine levels^[3]. Genetic studies continue to identify loci associated with kidney function and CKD, contributing to a deeper understanding of individual predispositions and potential therapeutic targets.

Limitations

Research into the genetic basis of serum creatinine amount, a key indicator of kidney function, faces several methodological and biological challenges. These limitations impact the interpretation and generalizability of findings, highlighting the need for continued, more comprehensive studies.

Methodological and Statistical Considerations

Current genome-wide association studies (GWAS) for serum creatinine amount, like those for many complex traits, are often subject to methodological and statistical constraints. A primary concern is the need for replication, as initial associations may represent false positives if not independently validated in diverse cohorts^[4]. The absence of external replication can lead to an overestimation of effect sizes and an incomplete picture of true genetic signals. Furthermore, the selection of genetic markers for GWAS, typically a subset of all known SNPs, means that some causal variants or genes influencing serum creatinine amount might be missed due to incomplete genomic coverage, limiting the comprehensive understanding of the trait’s genetic architecture^[5].

Study design choices also influence the depth of insights gained. For instance, pooling data from both sexes to manage the multiple testing burden can obscure sex-specific genetic associations with serum creatinine amount, potentially leading to undetected variants that manifest differently in males and females^[5]. Similarly, an exclusive focus on multivariable models might lead to overlooking simpler, yet important, bivariate associations between individual genetic markers and kidney function traits ^[6]. These analytical decisions underscore the challenge of balancing statistical power with the nuanced exploration of complex genetic influences.

Generalizability and Phenotypic Nuance

A significant limitation in studies of serum creatinine amount is the restricted generalizability of findings, primarily due to the composition of study populations. Many cohorts are not ethnically diverse, often consisting predominantly of individuals from specific ethnic backgrounds, such as non-Hispanic White populations^[7]. This lack of broad ethnic representation raises concerns about how identified genetic associations apply to other populations, given that genetic architectures, allele frequencies, and environmental exposures can vary significantly across different ancestries ^[6]. Consequently, findings from one population may not be universally applicable, necessitating extensive replication and investigation in globally diverse groups.

Beyond population issues, the precise measurement and definition of kidney function, often inferred from serum creatinine amount, also present challenges. While serum creatinine is a widely accepted marker, its use in estimating glomerular filtration rate (GFR) relies on equations that may have been developed in smaller, selected samples or using specific laboratory methodologies^[6]. Discrepancies in these methods or the characteristics of the derivation cohorts can introduce variability and affect the accuracy of GFR estimations, thereby impacting the comparability and interpretation of genetic associations across different studies. The inherent variability of creatinine levels due to factors such as muscle mass, diet, and hydration status further complicates its interpretation as a sole indicator of kidney health.

Environmental Factors and Etiological Gaps

The amount of serum creatinine is influenced by a complex interplay of genetic predispositions and environmental factors, posing challenges for fully elucidating its etiology. Non-genetic confounders, such as age and various comorbid diseases like chronic kidney disease, type 2 diabetes, and kidney stones, significantly impact creatinine levels and kidney function^[2]. These environmental and disease-related influences can modulate or mask the effects of genetic variants, making it difficult to isolate the precise contribution of individual genes. A comprehensive understanding requires accounting for these intricate gene-environment interactions, which are often not fully captured in current study designs.

Despite the identification of numerous genetic loci associated with serum creatinine amount and kidney function, a substantial portion of the heritability for these traits remains unexplained, a phenomenon referred to as “missing heritability.” This suggests that many genetic variants, particularly those with small effect sizes, rare alleles, or complex epistatic interactions, are yet to be discovered^[5]. Moreover, while GWAS can pinpoint regions of the genome associated with the trait, they often do not fully elucidate the underlying biological mechanisms or affected pathways. Significant knowledge gaps persist regarding how identified genetic variants functionally impact creatinine metabolism or kidney physiology, highlighting the need for further functional validation and integration of multi-omics data to bridge these etiological gaps.

Variants

Genetic variations play a crucial role in influencing serum creatinine levels, a key indicator of kidney function. These variants can affect genes involved in the kidney’s filtration and reabsorption processes, creatine metabolism, and overall kidney health and development. Understanding these genetic influences helps clarify the biological mechanisms underlying variations in kidney function.

Variants within genes like UMOD, SHROOM3, GATM, and PRKAG2 are significantly associated with kidney function. UMOD encodes uromodulin, the most abundant protein in mammalian urine, which is involved in kidney stone formation and defense against urinary tract infections. Genetic variations in UMOD, such as rs36060036 , rs13329952 , and rs9928003 , along with the well-studied rs12917707 at the UMODlocus, are consistently linked to kidney function and chronic kidney disease, likely by affecting uromodulin production or its role in tubular transport^[1]. PDILT, a gene located near UMOD, may also interact with these renal processes. SHROOM3 is essential for cell shape and tissue development, particularly in kidney epithelial cells. Variants in SHROOM3, including rs4859682 , which is in high linkage disequilibrium with rs17319721 , are strongly associated with estimated glomerular filtration rate (eGFR), suggesting their impact on the structural integrity and function of the kidney’s filtration barrier ^[1]. GATMencodes Glycine Amidinotransferase, an enzyme critical for creatine synthesis. Variations likers1288775 in GATM can influence the amount of creatine produced, thereby affecting serum creatinine levels, which is a direct measure of kidney function ^[1]. Additionally, PRKAG2, which codes for a regulatory subunit of the AMP-activated protein kinase (AMPK), an energy sensor, has been linked to renal function and disease, implying its role in kidney cell metabolism and the regulation of creatinine^[3].

Other genetic loci contribute to serum creatinine through different mechanisms, including creatinine production, secretion, and kidney development. BCAS3(Breast Carcinoma Amplified Sequence 3) contains variants such asrs7219624 , rs34895486 , and rs9905274 , which are considered to influence creatinine production or secretion rather than directly impacting glomerular filtration ^[3]. This highlights a role for BCAS3 in the metabolic pathways that generate creatinine or its cellular transport. Similarly, the TBX2 gene, encoding a T-box transcription factor crucial for developmental processes, including kidney formation, shows associations with creatinine and eGFR ^[1]. Variants in the TBX2-AS1 region could indirectly affect TBX2 expression, influencing kidney development or function. The SLC28A2gene, coding for a sodium-coupled nucleoside transporter, is important for the transport of various substances in the kidney. While not directly involved in creatinine transport, variants likers1060896 in SLC28A2 or its antisense RNA, SLC28A2-AS1, can affect overall renal physiology and drug metabolism, thereby influencing kidney health and serum creatinine levels. The extensive genetic studies on kidney function underscore the complex interplay of various genes in maintaining renal health ^[3].

Finally, several other genomic regions, including those containing AFG2B - C15orf48, MPPED2-AS1 - DCDC1, and SLC28A2-AS1 - RNU6-953P, also harbor variants that may impact kidney function and serum creatinine. C15orf48, also known as FAAP24, is involved in DNA damage response, a fundamental cellular process ^[1]. Although a direct link to kidney function is not extensively reported, variants like rs2433601 in this region might subtly affect cellular repair mechanisms within the kidney, influencing its long-term health and creatinine levels. MPPED2-AS1 is a long non-coding RNA, and DCDC1 is involved in cell migration, suggesting that variants such as rs3925584 in this region could impact kidney development or cellular responses to injury. Similarly, RNU6-953P, a small nuclear RNA involved in RNA processing, might, through variants like rs76825670 , affect gene expression and protein function in kidney cells. These genetic factors, even with less direct known mechanisms, contribute to the intricate network of pathways that regulate kidney function and, consequently, serum creatinine levels ^[6].

Key Variants

RS ID	Gene	Related Traits
rs77924615 rs7192797 rs35208507	PDILT	glomerular filtration rate chronic kidney disease blood urea nitrogen amount serum creatinine amount protein measurement
rs10224210 rs10224002 rs6464165	PRKAG2	hematocrit hemoglobin measurement glomerular filtration rate gout urate measurement
rs1288775 rs2486272 rs1145084	GATM	serum creatinine amount
rs2433601 rs36047699	AFG2B - C15orf48	glomerular filtration rate serum creatinine amount protein measurement
rs4859682 rs28394165 rs1986734	SHROOM3	glomerular filtration rate erythrocyte count hematocrit red blood cell density hemoglobin measurement
rs36060036 rs13329952 rs9928003	UMOD	CD27 antigen measurement corneodesmosin measurement trefoil factor 3 measurement tgf-beta receptor type-2 measurement thrombomodulin measurement
rs76825670 rs2453533 rs61524473	SLC28A2-AS1 - RNU6-953P	appendicular lean mass serum creatinine amount
rs7219624 rs34895486 rs9905274	BCAS3, TBX2-AS1	serum creatinine amount glomerular filtration rate urea measurement
rs3925584 rs963837 rs55733296	MPPED2-AS1 - DCDC1	magnesium measurement chronic kidney disease glomerular filtration rate blood urea nitrogen amount gout
rs1060896	SLC28A2, SLC28A2-AS1	serum creatinine amount

Classification, Definition, and Terminology

Definition and Measurement of Serum Creatinine

Serum creatinine amount refers to the concentration of creatinine, a metabolic waste product derived primarily from creatine phosphate in muscle, found in the blood serum. This physiological marker is predominantly filtered by the kidneys, making its levels a critical indicator for assessing renal function. Operational definitions often involve measuring serum creatinine to estimate the glomerular filtration rate (GFR), which quantitatively reflects the kidneys’ filtering capacity^[3]. The measurement of serum creatinine is therefore a foundational diagnostic approach in nephrology, providing insights into renal health.

To enhance the accuracy of kidney function assessment, prediction equations are frequently employed to estimate GFR from serum creatinine levels. One such approach, developed by the Modification of Diet in Renal Disease (MDRD) Study Group, offers a more precise method for GFR estimation than relying solely on serum creatinine concentration^[6]. These estimated GFR values serve as crucial diagnostic criteria, allowing for the classification of kidney function across a continuous scale, and are instrumental in identifying and monitoring individuals with impaired renal health. The continuous nature of serum creatinine and estimated GFR also allows for the observation of “intermediate phenotypes” which can provide more detailed insights into affected physiological pathways ^[8].

Clinical Classification and Associated Conditions

The amount of serum creatinine is integral to the clinical classification and stratification of chronic kidney disease (CKD), a significant health concern. The Kidney Disease Outcome Quality Initiative (K/DOQI) clinical practice guidelines provide a comprehensive system for the evaluation, classification, and staging of CKD, heavily relying on estimated GFR derived from serum creatinine levels^[6]. These guidelines establish severity gradations, moving from mild impairment to kidney failure, thereby providing a standardized framework for diagnosis and management. The classification of CKD is not merely categorical but often considers serum creatinine as a continuous variable, with specific thresholds defining disease stages.

Beyond direct kidney function, altered serum creatinine levels are frequently observed in conjunction with various comorbid diseases and risk factors. Research indicates that chronic kidney disease often clusters with conditions such as hypertension, diabetes, smoking, obesity, and low high-density lipoprotein (HDL) cholesterol^[6]. Furthermore, studies have identified familial clustering of chronic kidney disease, suggesting genetic and environmental predispositions that impact serum creatinine and GFR levels^[3]. These associations highlight the systemic implications of kidney dysfunction and the importance of serum creatinine in a broader clinical context.

Terminology and Clinical Significance

The terminology surrounding serum creatinine is central to understanding kidney health, with “serum creatinine,” “glomerular filtration rate (GFR),” and “creatinine clearance” being key terms used interchangeably or in conjunction to describe renal function^[3]. While serum creatinine provides a direct measurement, GFR offers a more comprehensive physiological assessment of the kidney’s filtering capacity, often estimated through standardized equations. The term “chronic kidney disease (CKD)” represents the overarching diagnostic category for persistent kidney dysfunction, which is primarily defined by GFR levels derived from serum creatinine.

The clinical significance of serum creatinine amount extends to its utility as a biomarker for early detection, monitoring, and prognostication of kidney disease. It serves as a readily available and cost-effective indicator that reflects changes in kidney function, crucial for managing conditions like type 2 diabetes and identifying susceptibility to various metabolic disorders^[3]. Standardized vocabularies, such as those established by K/DOQI guidelines, ensure consistent interpretation and application of serum creatinine measurements across clinical and research settings, facilitating effective communication and patient care.

Genetic Influences on Creatinine Levels

The amount of serum creatinine is significantly shaped by an individual’s genetic makeup, with research indicating a clear heritable component to kidney function. Familial clustering of chronic kidney disease (CKD) and end-stage renal disease has been observed, suggesting that inherited genetic variants play a crucial role in predisposing individuals to altered renal function^[3]. Genome-wide linkage analyses have successfully identified numerous loci associated with serum creatinine, glomerular filtration rate (GFR), and creatinine clearance, mapping these to various chromosomes including 1, 2, 3, 4, 7, 10, 12, 18, and 19^[3]. Specific genetic variants, such as those within the UMODgene, have been linked to chronic kidney disease and kidney stones, highlighting the polygenic nature of creatinine regulation and the potential for Mendelian forms of kidney disorders to impact creatinine levels^[2].

Further studies have used genome-wide association studies (GWAS) to pinpoint additional genetic loci influencing kidney function and CKD, underscoring the complex interplay of multiple genes in determining an individual’s baseline creatinine and their susceptibility to kidney dysfunction ^[1]. For instance, SNPs like rs10502302 have been associated with serum creatinine levels, and other variants on chromosomes like 4 (within RAP1GDS1) and X (within ZCCHC16) are also implicated in biochemical traits potentially related to kidney function ^[6]. These findings collectively demonstrate that both common and rare inherited variants contribute to the variability in serum creatinine amount, often through their impact on kidney structure, function, and metabolic pathways.

Acquired Factors: Lifestyle, Age, and Comorbidities

Beyond genetics, a range of acquired factors significantly influence serum creatinine levels. Advancing age is a major contributor, with studies indicating a dramatic increase in the prevalence of chronic kidney disease as individuals get older^[2]. Certain lifestyle choices and environmental exposures can also impact kidney health; for example, nephrotoxic drugs are recognized as a cause of CKD, which can lead to elevated creatinine^[2].

Furthermore, the presence of comorbid diseases is a primary driver of altered creatinine amounts. Hypertension and diabetes mellitus are identified as the most important causes of chronic kidney disease, directly affecting renal function and, consequently, serum creatinine levels^[2]. Other conditions such as intrinsic kidney disorders and atherosclerosis also contribute to kidney dysfunction and can elevate creatinine, reflecting a broader impact of systemic health on renal markers^[2].

Gene-Environment Interactions

The ultimate serum creatinine amount often results from intricate interactions between an individual’s genetic predisposition and various environmental and lifestyle factors. While genetic variants confer a certain susceptibility to kidney disease and influence baseline creatinine, the manifestation and progression of renal dysfunction can be significantly modulated by external triggers^[2]. For instance, an individual with a genetic predisposition to chronic kidney disease, perhaps due to variants in genes likeUMOD, may experience an accelerated decline in kidney function when exposed to environmental stressors such as nephrotoxic medications or in the presence of comorbidities like uncontrolled hypertension or diabetes^[2]. This complex interplay suggests that genetic insights can help identify at-risk individuals, while environmental and lifestyle interventions remain crucial in managing and mitigating the impact on serum creatinine levels and overall kidney health.

Creatinine Production and Renal Clearance

Creatinine is a fundamental biomolecule derived from the metabolic breakdown of creatine phosphate, primarily within skeletal muscles. This waste product is continuously generated at a relatively constant rate, reflecting an individual’s muscle mass, and its presence in the serum serves as a crucial indicator of kidney function -stage renal disease . These genetic variants play a crucial role in regulating gene expression and the function of proteins involved in creatinine metabolism, filtration, and excretion. For instance, variants near theUMODgene are strongly associated with chronic kidney disease (CKD) and kidney stone formation, suggesting a direct role for uromodulin in renal physiology^[2]. The identification of such loci provides fundamental insights into the genetic architecture underlying individual variability in renal health and the homeostatic control of creatinine ^[8].

Metabolic Interplay and Creatinine Levels

Creatinine, as a metabolic byproduct of creatine, is deeply intertwined with broader metabolic pathways, and its circulating levels are indicative of metabolic regulation. Research into metabolite profiles in human serum has begun to detail the specific metabolic pathways affected by genetic variation, underscoring creatinine’s role as a key metabolite^[8]. Furthermore, there are robust associations between genetic variants that impact fasting glucose levels and diabetes-related traits with kidney function and the risk of chronic kidney disease^[1]. This demonstrates a critical metabolic crosstalk where dysregulation in glucose homeostasis, potentially influenced by genes such asMTNR1B and FOXA2, can indirectly but significantly affect renal function and, consequently, the amount of serum creatinine ^[1].

Kidney Disease Mechanisms and Creatinine Dysregulation

Elevated serum creatinine is a primary biomarker of impaired kidney function and chronic kidney disease, directly reflecting dysregulation within the intricate renal filtration and excretory pathways^[1]. Genetic variants associated with kidney function and CKD illuminate specific disease mechanisms, such as those involvingUMOD, which is critical for maintaining kidney health and influencing susceptibility to conditions like kidney stones ^[2]. Pathway dysregulation in CKD often involves a complex interaction of genetic predispositions and metabolic stressors, leading to a progressive decline in the glomerular filtration rate and altered creatinine clearance^[1]. A deeper understanding of these disease-relevant mechanisms is essential for identifying potential therapeutic targets and developing effective strategies to slow or prevent the progression of kidney disease.

Integrated Regulatory Networks in Renal Health

The precise regulation of serum creatinine levels and kidney function is achieved through intricate systems-level integration, where diverse genetic, metabolic, and physiological pathways interact in a coordinated manner. Studies have revealed significant pathway crosstalk between genetic loci influencing fasting glucose and those impacting kidney function, illustrating how metabolic health is hierarchically linked to renal integrity^[1]. The discovery of variants associated with multiple biomarker traits, including creatinine and various diabetes-related markers, highlights the complex network interactions that maintain overall physiological homeostasis ^[4]. These emergent properties, arising from the convergence of diverse regulatory mechanisms, provide a comprehensive understanding of renal health and susceptibility to kidney-related diseases.

Clinical Relevance

The amount of serum creatinine serves as a fundamental biomarker in clinical practice, offering critical insights into kidney health and overall physiological status. Its clinical relevance extends across diagnostic, prognostic, and therapeutic domains, guiding patient management and risk stratification.

Assessment of Renal Function and Disease Progression

Serum creatinine is a cornerstone for evaluating renal function, primarily utilized to estimate the glomerular filtration rate (GFR). This estimation is crucial for identifying kidney dysfunction, with established methodologies like the Modification of Diet in Renal Disease (MDRD) Study Group’s prediction equation providing a more accurate assessment of GFR^[9]. Regular monitoring of creatinine levels and estimated GFR is essential for tracking the progression of chronic kidney disease (CKD), enabling clinicians to tailor monitoring strategies and interventions. These measurements are integral to the evaluation, classification, and stratification guidelines, such as those published by the Kidney Disease Outcome Quality Initiative, which provide frameworks for comprehensive patient care^[6].

Risk Stratification and Comorbidity Associations

Creatinine levels are vital for identifying individuals at elevated risk for chronic kidney disease and its associated complications. Research indicates a familial clustering of CKD and has identified multiple genetic loci influencing renal function, highlighting a genetic predisposition to the disease^[2]. Elevated creatinine, indicative of impaired kidney function, is strongly linked to an increased burden of cardiovascular disease risk factors, including hypertension, diabetes, smoking, obesity, and low HDL cholesterol^[6]. Furthermore, specific genetic variants, such as those at UMOD, are associated with both CKD and kidney stones, underscoring the importance of considering overlapping phenotypes and comorbid conditions in comprehensive risk stratification ^[2]. The intricate relationship between metabolic health and kidney function is further exemplified by genetic variations near MTNR1B and FOXA2, which influence plasma glucose levels and the risk of type 2 diabetes, a significant comorbidity for kidney disease^[1].

Genetic Insights and Personalized Medicine

Genome-wide association studies (GWAS) have significantly advanced the understanding of the genetic architecture underpinning serum creatinine levels and kidney function. These studies have successfully identified specific genetic loci that exert a substantial impact on kidney function and susceptibility to chronic kidney disease^[1]. The identification of such genetic variants opens avenues for personalized medicine approaches, allowing for the earlier identification of high-risk individuals before overt clinical symptoms manifest. This genetic information can facilitate the development of targeted prevention strategies and more precise interventions, ultimately aiming to improve long-term outcomes for patients by moving beyond traditional clinical markers to a more refined risk assessment ^[1].

Frequently Asked Questions About Serum Creatinine Amount

These questions address the most important and specific aspects of serum creatinine amount based on current genetic research.

---

1. Does lifting weights make my kidney tests look bad?

Yes, it can. Creatinine is a waste product from muscle breakdown, and the amount produced is proportional to your muscle mass. If you have a lot of muscle from lifting weights, your baseline creatinine levels might be slightly higher than someone with less muscle, even with healthy kidneys. Doctors consider your muscle mass when interpreting these results to avoid misinterpreting a normal variation as a kidney problem.

2. Can eating lots of protein change my creatinine results?

Yes, your diet can influence creatinine levels. Very high protein intake, for example, can temporarily increase creatinine production, as diet is one of the factors that can cause variability in its levels. It’s important to discuss your typical diet with your doctor before a blood test, especially if you’re on a high-protein regimen.

3. Will my creatinine levels go up just because I’m getting older?

Yes, age is a known factor that influences serum creatinine levels. As you get older, kidney function can naturally decline, which might lead to a gradual increase in creatinine. Doctors account for age when estimating your kidney function, as what’s considered normal can vary across different age groups.

4. My family has kidney issues; does that mean I’m next?

Not necessarily, but it does mean you might have a higher predisposition. Research suggests there’s a familial clustering of chronic kidney disease, indicating both environmental and genetic factors play a role. While genetics can increase your risk, early detection through markers like creatinine and managing lifestyle factors can help prevent or slow disease progression.

5. Could my routine medications mess with my kidney numbers?

Yes, certain medications are known to influence serum creatinine levels, potentially making them appear higher or lower than they truly are, or directly affecting kidney function. This is why it’s crucial to inform your doctor about all medications, supplements, and over-the-counter drugs you are taking when interpreting your kidney test results.

6. Does my ethnic background affect what’s considered normal for my kidneys?

It can. Studies on serum creatinine and kidney function have often lacked ethnic diversity, primarily focusing on specific populations. Genetic architectures and allele frequencies can vary significantly across different ancestries, meaning that what’s considered a “normal” range or how certain equations estimate kidney function might need to be interpreted differently based on your ethnic background.

7. If I feel totally healthy, why is my doctor checking my creatinine?

Your doctor checks it because kidney diseases are often asymptomatic in their initial stages. Measuring serum creatinine is a standard diagnostic tool that helps estimate how well your kidneys are filtering blood, even when you feel fine. Early detection allows for interventions that can slow disease progression and prevent severe complications, improving your long-term health.

8. I’ve had kidney stones; does that make my creatinine unreliable?

Having a history of kidney stones is a comorbidity that can impact kidney function and creatinine levels. While creatinine is a key indicator, conditions like kidney stones can be associated with variations in kidney health. Your doctor will interpret your creatinine levels in the context of your medical history, including past kidney stone episodes, to get an accurate picture of your kidney health.

9. Why might my creatinine be different from someone else my age?

Many factors contribute to individual differences. Even among people of the same age, variations in muscle mass, diet, hydration status, medications, and underlying genetic predispositions can all affect creatinine levels. Healthy kidneys efficiently remove creatinine, but these individual differences mean everyone’s “normal” can vary slightly.

10. Does drinking less water change my creatinine test results?

Yes, your hydration status can definitely affect your creatinine levels and how kidney function is estimated. Dehydration can lead to a temporary increase in serum creatinine because the kidneys are not filtering as efficiently. This variability makes it important to consider factors like hydration when interpreting your results.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Chambers JC, Zhang W, Lordan N, van der Harst P, Lawlor DA, Metter EJ et al. “Genetic loci influencing kidney function and chronic kidney disease.”Nat Genet, 2010.

[2] Gudbjartsson, DF et al. “Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.”PLoS Genet. 20686651.

[3] Kottgen A, Glazer NL, Dehghan A, et al. “New loci associated with kidney function and chronic kidney disease.”Nat Genet, vol. 42, no. 5, May 2010, pp. 376-81. PubMed, PMID: 20383146.

[4] Benjamin, E. J. et al. “Genome-wide association with select biomarker traits in the Framingham Heart Study.” BMC Med Genet, 2007.

[5] Yang, Qiong, et al. “Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.”BMC Medical Genetics, 2007. PMID: 17903294.

[6] Hwang SJ, Seshadri S, Vasan RS, et al. “A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study.” BMC Med Genet, vol. 8, suppl. 1, 2007, p. S11. PubMed, PMID: 17903292.

[7] Chalasani, N et al. “Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.”Gastroenterology. 20708005.

[8] Gieger C, Ekici AB, Heid IM, et al. “Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.”PLoS Genet, vol. 4, no. 11, Nov. 2008, p. e1000282. PubMed, PMID: 19043545.

[9] Levey, AS et al. “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.”Ann Intern Med. 1999.